Industry
Drug Manufacturers - Specialty & Generic
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Loading...
Open
17.59
Mkt cap
795M
Volume
705K
High
18.30
P/E Ratio
-8.71
52-wk high
35.95
Low
17.19
Div yield
N/A
52-wk low
11.16
Portfolio Pulse from
November 07, 2024 | 4:30 pm
Portfolio Pulse from
November 06, 2024 | 11:30 pm
Portfolio Pulse from Benzinga Newsdesk
October 21, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Newsdesk
October 04, 2024 | 3:54 pm
Portfolio Pulse from Benzinga Newsdesk
October 03, 2024 | 12:12 pm
Portfolio Pulse from Benzinga Newsdesk
September 26, 2024 | 12:14 pm
Portfolio Pulse from Benzinga Newsdesk
September 25, 2024 | 12:17 pm
Portfolio Pulse from Benzinga Insights
September 24, 2024 | 4:00 pm
Portfolio Pulse from Benzinga Newsdesk
September 24, 2024 | 3:43 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.